Company / CapEx per Share
BIOCRYST PHARMACEUTICALS INC CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.01 / $0.01
FY2021-FY2025
Trend
+107.6%
vs FY2024
Sector context
#120 of 192
Health Care
What the data says
At $0.01, BIOCRYST PHARMACEUTICALS INC's capex per share ranks #120 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2019 to $0.07 in FY2016.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of +29.7%.
Remained stable around $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +15.8%
- 5-Year CAGR
- +29.7%
- 10-Year CAGR
- -
Sector benchmark
#120 of 192 in Health CareTop 62% of 192This company $0.01 Sector average $2.46
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 107.6% year-over-year.
- Ranks #120 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2016.
- Lowest capex per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +107.6% |
| FY2024 | $0.01 | -51.8% |
| FY2023 | $0.01 | +55.2% |
| FY2022 | $0.01 | -45.4% |
| FY2021 | $0.01 | +333.3% |
| FY2020 | $0.00 | +3.6% |
| FY2019 | $0.00 | -16.3% |
| FY2018 | $0.00 | -20.2% |
| FY2017 | $0.00 | -93.8% |
| FY2016 | $0.07 | +1.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026